Navigation Links
Natural Remedies Ineffective to Ease Menopausal Symptoms:study

For most women, menopause passes by uneventfully .But for about 10% to 20 % of women menopausal period can be quite appalling.They suffer symptoms such as night sweats, hot// flashes (sensation of heat which comes on all of a sudden), and many more.

Hormonal Replacement Therapy (HRT) is the conventional treatment of choice that is advised for women who suffer unpleasant symptoms during their menopausal period. Hormone therapy offers great relief from hot flashes and night sweats but raises the risk of cardiac complaints and breast cancer.

Black Cohosh, a dietary herbal supplement, was considered an effective alternative to hormone therapy,by many women .But a recent study has proven that Black Cohosh and certain other herbal supplements are ineffective in reducing hot flashes and night sweats.

Reseachers studied about 351 women in their late forties and early fifties, in whom the effect of using Black Cohosh was scrutinised .The lead researcher Katherine Newton, in Seattle, opined that it was disappointing but true that Black Cohosh or other natural remedies are not effective to supplement HRT. The Annals of Internal Medicine published the study.

A member of Buttercup family, Black Cohosh, is plant that grows in North America, from which various medicines are made by native Indians to treat illnesses, including female disorders. Black Cohosh was used by many women to ease night sweats and hot flashes.

The women who took part in the study were randomly divided into five groups. One group were treated with Black Cohosh, the second group was given a concoction of Black Cohosh along with other herbal ingredients like, oats, licorice, alfa alfa, Siberian ginseng and pomegranate. The third group were advised addition of soy supplements to their diet in addition to the herbal concoction given to group 2.The fourth group were advised hormone therapy. The last group were put on placebo.

The women on hormonal the
'"/>




Page: 1 2

Related medicine news :

1. Accuracy of Some Natural Family Planning Methods Questioned .
2. Natural formula for protection against vision loss
3. Naturally Occurring Hormone Can Lead To Miscarriage
4. Treating Leukemia With Natural Cells
5. Natural Sulfur Can Treat Pain From Osteoarthritis
6. Chronic Post-Traumatic Stress Disorder (PTSD) Risk In Young Natural Disaster Survivors
7. Tsunami Unplugged: Natural Disasters Favor the Under-privileged
8. ‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scientit
9. An After-Dinner Nap Is A Natural Thing, Scientists Proved
10. The Most Natural Thing in the World
11. Natural Approach to Immune Regulation May Help Transplant Patients
Post Your Comments:
(Date:7/2/2009)...ncer patients who receive brachytherapy and remain...ikely to have a recurrence at 10 years, according ...al Journal of Radiation Oncology*Biology*Physics ,...Radiation Oncology (ASTRO)., Brachytherapy is the...to a tumor either permanently or temporarily, depe...
(Date:7/2/2009)..., Tenn., July 2 Emdeon, a leading p...lutions, today announced the acquisition of eRx Ne...ic pharmacy healthcare solutions. The transaction ...h eRx,s expanding customer base, reputation for pr...armacy switching technology. Terms of the acquisit...
(Date:7/2/2009)...se is available in Spanish . , Sexist jokes (...r the mental mechanisms which urge to violence and... attitudes. Those are the conclusions of a study c...ll be released tomorrow Thursday 2nd of July in th...al symposium about humour and its scientific appli...
(Date:7/2/2009)... , DEARBORN, Mich., July 2 It,s o... the voting helps out a good cause. , , Starti...c is invited to visit www.jdrf.org/ford , view ...eir favorite children,s design by making a monetar...ervice Division,s second annual Funny Car Design C...
Breaking Medicine News(10 mins):Health News:Emdeon Acquires eRx Network, LLC 2Health News:Emdeon Acquires eRx Network, LLC 3Health News:Sexist jokes favor the mental mechanisms that justify violence against women 2Health News:Online Voting Begins for Ford Customer Service Division's Second Annual Funny Car Design Contest to Support Juvenile Diabetes Research Foundation 2Health News:Online Voting Begins for Ford Customer Service Division's Second Annual Funny Car Design Contest to Support Juvenile Diabetes Research Foundation 3Health News:Online Voting Begins for Ford Customer Service Division's Second Annual Funny Car Design Contest to Support Juvenile Diabetes Research Foundation 4
...versity in New York City has discovered that chron...ons. // He and his colleagues were studying chroni...ly at the molecular level a pain stimulus occurs a... to send signals to the brain and the individual s...
...f chikunguniya have been reported from across the ... and logistic support to tackle the disease // , U... said here today. The cases have been reported fr...he said at a review meeting with the Andhra Prades...
...lma Garcia, 41, were well aware of the toll that m...suffering from high blood pressure, diabetes and t...ve bone disease.// When they scheduled their gast...edical Center on the same day in February 2006, th...
...on University verified the health benefits of a ve...ss the potential of both categories in the managem...ls and weight loss.// The study was conducted on ...lf the group was asked to follow a low fat vegetar...
Other Medicine News:Health News:Weight-Loss Surgeries Changing Lives 2Health News:Weight-Loss Surgeries Changing Lives 3Health News:Weight-Loss Surgeries Changing Lives 4
(Date:7/1/2009)..., Denmark, July 1 A just...ion on Investigational Drugs", Volume,18, Issue 7... on,PROSTVAC(TM). This is the most comprehensive ... Quote from the article: "Preliminary clinical t...se II trials have suggested a survival benefit,af...
(Date:6/30/2009)...une 30 Cephalon, Inc. (N...ted a supplemental New Drug Application (sNDA) to ...ting approval of NUVIGIL(R) (armodafinil) Tablets ...in patients with excessive sleepiness associated w...el. Jet lag disorder is an acute condition that o...
(Date:6/29/2009)...n., June 29 Pioneering...ss of deep brain stimulation (DBS) in hard-to-...CD) and Tourette,s syndrome are underway at multip...a review in the June 2009 issue of Mayo Clini... been seen as valuable for controlling movement di...
(Date:6/28/2009)...f., June 29 Sangamo BioS...at a key research milestone has been achieved in i...Inc., a wholly-owned member of the Roche Group, fo...ristics for pharmaceutical protein production purp...inding protein nuclease (ZFN) technology. Genentec...
Breaking Medicine Technology:New Review on PROSTVAC(TM) Published by Key Investigators From NCI 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 3Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 3Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 1Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 2Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 3Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 4Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 5Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 6Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 7Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 8Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 9Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 10Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 11Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 12Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months 4016 13WallSt net 28www wallst net 29 Updates the Investment Community Through All New Interviews With XMDC POSS and TYPE 4014 1WallSt net 28www wallst net 29 Updates the Investment Community Through All New Interviews With XMDC POSS and TYPE 4014 2WallSt net 28www wallst net 29 Updates the Investment Community Through All New Interviews With XMDC POSS and TYPE 4014 3Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 28MEDI 538 29 in Patients with Acute Lymphoblastic Leuk 4012 1Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 28MEDI 538 29 in Patients with Acute Lymphoblastic Leuk 4012 2Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 28MEDI 538 29 in Patients with Acute Lymphoblastic Leuk 4012 3Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 28MEDI 538 29 in Patients with Acute Lymphoblastic Leuk 4012 4Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 28MEDI 538 29 in Patients with Acute Lymphoblastic Leuk 4012 5Lilly Delivers Strong Third Quarter Results 4010 1Lilly Delivers Strong Third Quarter Results 4010 2Lilly Delivers Strong Third Quarter Results 4010 3Lilly Delivers Strong Third Quarter Results 4010 4Lilly Delivers Strong Third Quarter Results 4010 5Lilly Delivers Strong Third Quarter Results 4010 6Lilly Delivers Strong Third Quarter Results 4010 7Lilly Delivers Strong Third Quarter Results 4010 8Lilly Delivers Strong Third Quarter Results 4010 9Lilly Delivers Strong Third Quarter Results 4010 10Lilly Delivers Strong Third Quarter Results 4010 11Lilly Delivers Strong Third Quarter Results 4010 12Lilly Delivers Strong Third Quarter Results 4010 13Lilly Delivers Strong Third Quarter Results 4010 14Lilly Delivers Strong Third Quarter Results 4010 15Lilly Delivers Strong Third Quarter Results 4010 16Lilly Delivers Strong Third Quarter Results 4010 17Lilly Delivers Strong Third Quarter Results 4010 18Lilly Delivers Strong Third Quarter Results 4010 19
...E)--May 14, 2007 - Acceleron Pharma,Inc., a bioph...he,treatment of musculoskeletal, metabolic and can... preclinical study with,ACE-031 that demonstrated ...s and strength in normal mice and in murine models...regulators of muscle,to increase muscle mass and s...
...f market dynamics offers insights into,what will b...,patients, NEW YORK, May 14, 2007 /PRNewswire-USNe...ent (TB Alliance), a not-for-profit,product devel...development of new TB drugs, today released result...cs of the global TB drug market,that offers a deta...
Other Medicine Technology:Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 2Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 2New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 4
...es fingertip ratchet disengagement allowing smooth...t program offers state-of-the-art quality in an in...ng strength and durability. Low profile cutting ti.... Series I instruments are available in just about...
A broad selection of procedurally specific tip configurations provide maximum grasping capability and allow easy access to all areas of the meniscus from a variety of approaches.,Loop Handled Grasper
Smith & Nephew ACUFEX scissors are constructed without pins for maximum strength, dependability, durability, and safety.,A wide range of tips and angles enable the surgeon to effectively dissect any
Used where access is required into superior meniscal flap region.
Medicine Products: